Early Development Lead Medical Director, Oncology
Notify me about similar jobsAbout this opportunity
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come. Join Roche, where every voice matters.
The Position
The Position
In Roche’s China Early Development (ED) Center of Excellence (CoE), we play a critical role in accelerating the global early development of transformative medicines for patients in order to tackle some of the world’s toughest unmet healthcare needs. We are a strategic partner to global early development teams of Roche Pharma Research and Early Development (pRED), Genentech Research and Early Development (gRED), and pharma Product Development (PD) to integrate China into the global early development programs. Together, we bring forward extraordinary life-changing innovation at speed.
This position is located in the clinical science function of Roche Product Development China, home of the China ED CoE. This position is dedicated to leading and driving early development programs in oncology and hematology therapeutic areas as a clinical lead.
The Opportunity
This role will have the opportunity to shape global early development strategy and CDP, to drive innovative early development trial design, to make significant impacts to the efficiency and success of our early development programs in oncology/hematology, and contribute to the China drug development innovation ecosystem.
In your role, you will:
Contribute to and influence global asset strategy and early development CDP as a member of the global asset teams
Proactively identify opportunities of accelerating and optimizing global ED CDP leveraging expertise, experience, speed, and scale in China
Lead the China cross-functional team to evaluate opportunities of China joining global ED programs or China-first trials from strategic, scientific, regulatory, and operational perspectives
Drive innovative trial design and trial conduct in close partnership with global early development functional experts on China-first clinical trials
Being the Medical Monitor for China ED clinical trials
Scientifically engage China TAEs, Roche internal and external stakeholders
Serve as a scientific point of contact to global early development asset teams of oncology/hematology
Mentor junior medical directors to further build capability and capacity of ED CoE
Who you are
You hold a MD in oncology/hematology, or a Bachelor/Master of Clinical Medicine with at least 3 years of post-graduation clinical practice in oncology/hematology
You have a minimum of 5 years of experience in biopharmaceutical industry and extensive early development experience in oncology/hematology
You have hands-on experience in developing early development CDP, designing and running early development clinical trials, interacting with Health Authorities, collaborating with investigators and clinical research You have a very good understanding of oncology/hematology global development guidelines and regulations, including CDE, FDA and EMEA
You are an effective communicator: Excellent written and verbal English communication skills, with the ability to present complex concepts to global cross functional teams, governance committees and key stakeholders in a logical and succinct manner
You are a great team player; highly collaborative, good interpersonal and influencing skills, can influence without authority
Who we are
A healthier future drives us to innovate. Together, more than 100’000 employees across the globe are dedicated to advance science, ensuring everyone has access to healthcare today and for generations to come. Our efforts result in more than 26 million people treated with our medicines and over 30 billion tests conducted using our Diagnostics products. We empower each other to explore new possibilities, foster creativity, and keep our ambitions high, so we can deliver life-changing healthcare solutions that make a global impact.
Let’s build a healthier future, together.
Roche is an Equal Opportunity Employer.
Job details
How this role compares
Computed from every other active Medical Affairs role in our database, not just this employer's listings.
We currently track 254 comparable Director Medical Affairs roles across 47 biopharma companies.
Salary context
131 of 254 peers report a salary range (USD, annualized)
Peers share this role's job function and a matching or adjacent seniority level -- not necessarily the same therapeutic area or country.
Where these roles are based
Top locations among the 254 comparable roles
+ 14 more countries
Seniority mix
254 of 254 peers have a known seniority level
Therapeutic area mix
111 of 254 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden
Similar opportunities
The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.
Open in 3 locations
Open in 3 locations
Notify me about similar jobs
Get an email when we spot other openings like this one – same job function, comparable seniority, roles you'd actually want to see.
How we calculate "similar"
No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.
Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.
0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.